This is a working overview of refrigeration, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-28 and is reviewed periodically as new material appears.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | 39-residue synthetic peptide |
| Average molecular mass | About 4813.5 Da | Free base form |
| Appearance | White to off-white powder | Solid after lyophilization |
| Solubility class | Freely soluble in water | Also soluble in neutral aqueous buffers |
| Typical storage | At or below -20 °C, desiccated | Protect from light and moisture |
Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.
Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.
Storage recommendations for tirzepatide generally specify refrigeration at 2–8 °C to maintain stability. The peptide should be protected from light and kept in its original packaging to prevent aggregation or adsorption. Freezing is not recommended because freeze-thaw cycles can cause aggregation or precipitation. Once dispensed, storage conditions and in-use periods follow product-specific labeling, which may allow room temperature storage for a limited time.
Identity and purity are established with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion verifies the primary sequence and detects substitutions. Size-exclusion chromatography quantifies aggregates and fragments, which are the impurities most often tracked for peptides of this size. Residual solvents, counterions, and water content fall under separate tests described in pharmacopeial chapters. Circular dichroism or nuclear magnetic resonance may be used in research settings to probe secondary structure, though such methods are less common in routine release testing.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
Purified material is typically handled as a lyophilized powder kept at or below minus twenty degrees Celsius, shielded from light and moisture. In that state the solid remains stable for extended periods, although repeated freeze-thaw cycling can encourage aggregation. Once dissolved, aqueous solutions are less durable and are generally held cold and used within a brief window. Buffer composition, pH and ionic strength all influence degradation rates, and mildly acidic to neutral conditions are commonly examined. Actual shelf life depends on formulation, concentration and container, so stability limits are established experimentally rather than assumed.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
== Career == Bigbie attended Ball State University. In 1998, he played collegiate summer baseball with the Wareham Gatemen of the Cape Cod Baseball League. Bigbie was drafted by the Baltimore Orioles in the 1st round (21st pick overall) of the 1999 Major League Baseball amateur draft and played over four years (2001–2005) for the Orioles before being traded during the 2005 season to the Colorado Rockies. Bigbie played the remainder of 2005 season for the Rockies. On December 8, 2005, the Rockies traded him and Aaron Miles to the St. Louis Cardinals for pitcher Ray King. On February 2, 2007, he signed a minor league deal with the Los Angeles Dodgers. Bigbie exercised a free agent option in his contract on June 1, 2007, and on June 11 signed a minor league contract with the Braves. During his six-year career, he posted a .268 batting average, hitting 31 home runs and amassing 322 hits in 375 games. Bigbie is an average fielder, but has an above-average arm. He batted .240 in 2006 with the Cardinals, also posting only 1 RBI, in 17 games. In December 2007, it was announced that he had agreed to a deal to play for the Yokohama Bay Stars of the Nippon Professional Baseball (NPB). Bigbie made a comeback for the 2010 season, playing for the Edmonton Capitals of the Golden Baseball League. Bigbie was named the DH for Baseball America's 2010 All-Independent Leagues Team.
In April 1943, Enrico Fermi suggested to Robert Oppenheimer the possibility of using the radioactive byproducts from enrichment to contaminate the German food supply. The background was fear that the German atomic bomb project was already at an advanced stage, and Fermi was also skeptical at the time that an atomic bomb could be developed quickly enough. Oppenheimer discussed the proposal with Edward Teller, who suggested the use of 90Sr. James Bryant Conant and Leslie R. Groves were also briefed, but Oppenheimer wanted to proceed with the plan only if enough food could be contaminated with the weapon to kill half a million people.
Intracellular Ang II is generated within cardiac cells either through internalization of circulating Ang II or by intracellular synthesis via non-secreted renin and angiotensinogen. Unlike its extracellular counterpart, intracrine Ang II does not rely on traditional cell surface receptors; instead, it binds to nuclear AT1 receptors, modulating gene transcription and intracellular signaling pathways. Studies have demonstrated that intracrine Ang II localizes to the nucleus and mitochondria of cardiac myocytes, where it influences cellular metabolism, oxidative stress, and calcium homeostasis. Additionally, intracellular Ang II has been shown to enhance the transcription of genes involved in hypertrophy and fibrosis, contributing to pathological cardiac remodeling.
The SAS raiding force, headed by Lieutenant-Colonel David Stirling, was discovered by an Italian reconnaissance unit, prompting Stirling to turn back to Kufra. The Rhodesians, meanwhile, were led into impassable country by a local guide, and swiftly retreated after being attacked by German bombers. Southern Rhodesian pilots played a part in the siege of Malta during 1942. John Plagis, a Rhodesian airman of Greek ancestry, joined the multinational group of Allied airmen defending the strategically important island in late March and on 1 April achieved four aerial victories in an afternoon, thereby becoming the siege's first Spitfire flying ace. By the time of his withdrawal in July he had been awarded the Distinguished Flying Cross twice. The British finally delivered vital supplies to Malta on 15 August with Operation Pedestal. Back in Salisbury, the Southern Rhodesian government was coming under pressure from Britain to put its armed forces under the purview of a regional command. Huggins decided in late October 1942 to join a unified Southern African Command headed by South Africa's Jan Smuts. This choice was motivated by a combination of strategic concerns and geopolitical manoeuvring. Apart from considering South Africa a more appropriate partner in geographical, logistical and cultural terms, Huggins feared that the alternative—joining the British East Africa Command—might detract from the autonomous nature of Southern Rhodesia's war effort, with possible constitutional implications. A shift in the deployment of the colony's troops duly occurred.
Pre-adipocytes are undifferentiated fibroblasts that can be stimulated to form adipocytes. Studies have shed light into potential molecular mechanisms in the fate determination of pre-adipocytes although the exact lineage of adipocyte is still unclear. The variation of body fat distribution resulting from normal growth is influenced by nutritional and hormonal status dependent on intrinsic differences in cells found in each adipose depot. Mesenchymal stem cells can differentiate into adipocytes, connective tissue, muscle or bone. The precursor of the adult cell is termed a lipoblast, and a tumor of this cell type is known as a lipoblastoma.
Sources: en.wikipedia.org
The common death adder (Acanthophis antarcticus) is a highly venomous snake species with a 50–60% untreated mortality rate. It is also the fastest striking venomous snake in the world. A death adder can go from a strike position, to strike and envenoming their prey, and back to strike position again, in less than 0.15 seconds. The SC LD50 value is 0.4 mg/kg and the venom yield per bite can range anywhere from 70–236 mg. Unlike other snakes that flee from approaching humans crashing through the undergrowth, common death adders are more likely to sit tight and risk being stepped on, making them more dangerous to the unwary bushwalker. They are said to be reluctant to bite unless actually touched.
Many described the separation from family members as excruciating, with some children being unable to talk to their parents, living with relatives in Gaza or having to monitor and parent younger siblings while their parents care for their injured siblings. On 16 August 2025, the U.S. State Department announced that it had suspended the issuance of visitor visas to people from the Gaza Strip, including children who require urgent medical care. In January–April 2024, medical evacuations for children from Gaza averaged about 296 per month; by late 2024 the rate had fallen to under one per day. In October 2024, UNICEF said children were dying not only from the violence itself but also because survivors were often unable to leave Gaza for urgent, life-saving treatment. By July/September 2025, an estimated 2,500-4,500 of critically wounded children are waiting for permits to be evacuated for care.
== Gingival fibers and periodontitis == In theory, gingival fibers are the protectors against periodontitis, as once they are breached, they cannot be regenerated. When destroyed, the gingival sulcus (labelled G in the diagram) increases in depth apically, allowing more debris and bacteria to remain in intimate contact with the delicate sulcular and junctional epithelia for longer times.
In 2024, circana tracked approximately 11,000 unauthorized flavored disposable vape products in U.S. mainstream retail outlets, according to data reviewed by Reuters. In 2024, illegal sales of flavored disposable vapes reached about $2.4 billion and accounted for roughly 35% of all e-cigarette sales in mainstream retail outlets. According to data reviewed by Reuters, Circana estimated the total tracked vape market at $6.8 billion, excluding online and specialty store sales. A 2025 lawsuit by New York's attorney general cited testimony that one distributor sold more than $132 million worth of Elf Bar e-cigarettes in the prior year. Altria Group, one of the largest tobacco companies in the United States and the owner of Philip Morris USA, has significant investments in the domestic e-cigarette market. In January 2025, Altria said it was reassessing its 2028 "smoke-free" volume and revenue goals, citing competition from disposable vapes, and estimated that illicit disposable products represent 60% or more of the U.S. e-cigarette category despite lacking required authorizations. US authorities reported intensified enforcement actions against unauthorized e-cigarettes in 2025, including seizures of 4.7 million units valued at $86.5 million in a Chicago-based operation; US agencies also reported blocking more than 6 million unauthorized e-cigarettes worth over $120 million that year.
== Background == The Druze largely remained neutral during the Syrian civil war. There are communities in Lebanon, Israel and Golan Heights, representing about three percent of Syria's population. On 31 December 2024, the As-Suwayda Joint Operations Room did not allow a convoy from the Syrian transitional government to enter Suwayda, after coordinating with the leader of the Ahrar Jabal al-Arab, Suleiman Abdul Baqi. The local Druze factions were excluded from the Syrian Revolution Victory Conference, where it was attended by the commanders of various armed revolutionary factions that fought for the Syrian opposition coalition against the deposed regime of Bashar al-Assad, in January 2025. In February 2025, local sources in Syria's Quneitra Governorate reported to Al Arabiya alleging that that the IDF had extended "tempting offers" of employment opportunities to residents of Syria. Druze factions in Syria are divided in their approach to the new authorities, ranging from cautious to outright rejection. In March 2025, Bahaa al-Jamal, a Druze commander in Suwayda, stated that massacres of Syrian Alawites by pro-government Islamist fighters had led to insecurity for other minorities, but the Druze had significant military capabilities with "thousands of military personnel" and the right to defend themselves if confronted by government forces.
Sources: en.wikipedia.org
=== Civil and criminal proceedings === In March 2018, the US Securities and Exchange Commission filed civil fraud charges against Theranos, its CEO Holmes and former president Ramesh "Sunny" Balwani, claiming they had engaged in an "elaborate, years-long fraud" wherein they "deceived investors into believing that its key product – a portable blood analyzer – could conduct comprehensive blood tests from finger drops of blood". Holmes reached a settlement with the SEC which required her to pay $500,000, forfeit 19 million shares of company stock, and be barred from having a leadership position in any public company for ten years. Balwani did not settle with the SEC. On June 15, 2018, Holmes and Balwani were indicted on multiple counts of wire fraud and conspiracy to commit wire fraud. According to the indictment, investors, doctors and patients were defrauded. It is alleged that the defendants were aware of the unreliability and inaccuracy of their products, but concealed that information. The case, United States v. Elizabeth A. Holmes, et al., was assigned to Lucy H. Koh, United States district judge of the United States District Court for the Northern District of California. The jury selection for the trial was to begin on July 28, 2020, and the trial was to have commenced in August 2020; however, the COVID-19 pandemic led to a proposed October date, before the trial for Holmes was rescheduled to begin on August 31, 2021, with Balwani's trial pushed back further to 2022.
== Uses == TCFH itself is a common reagent used in the preparation of uronium and guanidinium salts used for amide bond formation and peptide synthesis, such as HATU. Amide bond formation with TCFH can be performed in a wide range of organic solvents, most commonly acetonitrile, but also water and in the solid state. Reactions typically require an added Brønsted base, and a wide range can be employed including N,N-diisopropylethylamine (DIPEA). In reactions of carboxylic acids with TCFH and a weakly Lewis basic amine like DIPEA, formation of an acid chloride or anhydride as the active acylating agent occurs. Use of N-methylimidazole (NMI) as a base, with both Brønsted and Lewis basic properties, provides some unique advantages. Reactions of carboxylic acids with TCFH and a strongly Lewis basic amine like NMI lead to in situ formation of an N-acyl imidazolium ion (NAI) as the active acylating agent.
Dissolvable or swelling microneedles would provide those who are limited in their ability to seek hospital care with the ability to safely administer drugs in the comfort of their homes, although disposal of solid or hollow microneedles could still pose a needle-stick or blood borne pathogen infection risk. Another benefit of microneedles is their lower rates of microbial invasion into delivery sites. Traditional injection methods can leave puncture wounds for up to 48 hours post-treatment. This leaves a large window of opportunity for harmful bacteria to enter into the skin. Microneedles only damage the skin to a depth of 10-15μm, making it difficult for bacteria to enter the bloodstream and giving the body a smaller wound to repair. Further research is required to determine the types of bacteria able to breach the shallow puncture site of microneedles.
=== Obsessive–compulsive disorder === Fluoxetine is effective in the treatment of obsessive–compulsive disorder (OCD). It is effective for treating OCD in children, adolescents and adults. The American Academy of Child and Adolescent Psychiatry state that SSRIs, including fluoxetine, should be used as first-line therapy in children, along with cognitive behavioral therapy (CBT), for the treatment of moderate to severe OCD.
Sir Ninian Martin Stephen was selected by Queen Elizabeth II to become the next Governor-General of Australia, to take the place of Sir Zelman Cowen at the latter's retirement in July. Died: Marcel Camus, 69, French film director known for Black Orpheus (Orfeu Negro), winner of the 1959 Palme d'Or and the 1960 Academy Award for Best Foreign Language Film, died following open heart surgery.
Sources: en.wikipedia.org
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.
The C20 fatty diacid promotes tight binding to serum albumin. That binding reduces renal clearance and extends circulation time compared with an unmodified peptide of similar length.
It is not fully established. Studies indicate that both receptors contribute to the observed effects, but the exact split between the two signaling pathways in humans remains an open question.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.